CAS 1207989-09-0

LGD-6972

CAS : 1207989-09-0

LGD-6972

Degré de pureté : ≥98%

Masse moléculaire : 702.9g/mol

Ref: 54-BUP09525

LGD-6972

CAS : 1207989-09-0

LGD-6972 is a molecule that binds to the drug target of metformin, which is an oral anti-diabetic drug. LGD-6972 has shown that it can reduce hyperglycemia and insulin resistance in rats, as well as decrease blood pressure in mice. LGD-6972 has also been shown to be safe in a clinical study with patients with type 2 diabetes. This compound will be used as an oral treatment for type 2 diabetes and is currently undergoing phase 1 clinical trials.

Formule : C₄₃H₄₆N₂O₅S

Degré de pureté : Min. 95%

Masse moléculaire : 702.9 g/mol

Ref: 3D-HYB98909

LGD-6972

CAS : 1207989-09-0

LGD-6972 is an antagonist of glucagon receptor.

Formule : C₄₃H₄₆N₂O₅S

Degré de pureté : 98.8% - 99.62%

Couleur et forme : Solid

Masse moléculaire : 702.9

Ref: TM-T11845